EVMN — EVOMMUNE INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 111 SEC-registered investment managers reported holding EVMN (EVOMMUNE INC) in their latest 13F filings, with a combined reported value of $466.41M across 36.82M shares. That is +15.5% by share count (+4.37M shares) versus the previous quarter, while reported value moved -34.0%. Ownership is concentrated: the five largest holders account for 41.1% of reported value and the top ten for 60.9%.
Compared with the prior quarter, 46 opened new positions, 37 added to existing stakes, 13 trimmed, 21 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of EVOMMUNE INC (EVMN) include RA CAPITAL MANAGEMENT, L.P., EQT Fund Management S.a r.l., MPM BioImpact LLC, ranked by reported 13F value among the 151 institutional holders on this page.
EVMN is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 63 | 16.56M | $136.80M | -4.6% |
| Q2 2026 | 111 | 36.82M | $466.41M | +15.5% |
| Q1 2026 | 86 | 35.79M | $795.62M | +17.5% |
| Q4 2025 | 60 | 28.05M | $466.77M | — |
Over the 4 quarters shown, institutional share counts decreased 41% in aggregate (Q4 2025 → Q3 2026); the largest single-quarter swing was Q1 2026 (+17.5%).
Top Institutional Holders (Q3 2026) — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 5.29M | $43.68M | 4.61% | Hold | |
| 1.93M | $15.92M | 6.49% | Hold | |
| 1.44M | $11.90M | 8.04% | Hold | |
| 1.15M | $9.53M | 0.00% | Add | |
| 1.00M | $8.30M | 0.00% | Add | |
| 762.34K | $6.30M | 0.00% | Add | |
| 684.71K | $5.66M | 0.01% | Add | |
| 594.03K | $4.91M | 0.62% | New | |
| 526.56K | $4.35M | 0.01% | Add | |
| 467.27K | $3.86M | 0.00% | Add | |
| 330.03K | $2.73M | 0.00% | Add | |
| 267.91K | $2.21M | 0.00% | Add | |
| 243.51K | $2.01M | 0.00% | Add | |
| 168.77K | $1.39M | 0.00% | Add | |
| 158.81K | $1.31M | 0.03% | Add | |
| 158.16K | $1.31M | 0.00% | Add | |
| 152.82K | $1.26M | 0.00% | Add | |
| 136.26K | $1.13M | 0.00% | Add | |
| 127.31K | $1.05M | 0.00% | New | |
| 119.06K | $983.46K | 0.43% | Hold | |
| 97.36K | $804.21K | 0.46% | Reduce | |
| 94.57K | $781.17K | 0.00% | Reduce | |
| 84.02K | $694.03K | 0.01% | Add | |
| 79.70K | $658.29K | 0.00% | Add | |
| 78.97K | $652.27K | 0.00% | New |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 5.29M | $70.28M | 8.15% | Add | |
| 3.49M | $46.44M | 0.40% | Hold | |
| 1.94M | $25.80M | 0.00% | Add | |
| 1.93M | $25.61M | 8.32% | Hold | |
| 1.55M | $23.37M | 0.00% | Add | |
| 1.50M | $19.96M | 0.17% | Hold | |
| 1.44M | $19.15M | 14.56% | Hold | |
| 1.44M | $19.07M | 0.07% | Add | |
| 1.39M | $18.50M | 8.96% | Reduce | |
| 1.21M | $16.07M | 0.21% | Hold | |
| 1.00M | $13.29M | 0.31% | New | |
| 896.70K | $11.92M | 0.01% | New | |
| 886.54K | $11.78M | 0.00% | Add | |
| 881.89K | $11.72M | 0.00% | Add | |
| 847.39K | $11.26M | 0.06% | Hold | |
| 793.14K | $10.54M | 1.41% | Add | |
| 755.02K | $10.03M | 0.00% | Add | |
| 704.42K | $9.36M | 0.02% | Reduce | |
| 500.10K | $6.65M | 0.32% | New | |
| 451.25K | $6.00M | 3.84% | Add | |
| 413.55K | $5.50M | 0.00% | Add | |
| 325.00K | $4.32M | 0.01% | Hold | |
| 325.00K | $4.32M | 0.91% | Hold | |
| 306.33K | $4.07M | 0.03% | Reduce | |
| 301.76K | $4.01M | 0.00% | New |
Q1 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 4.93M | $113.33M | 11.10% | Hold | |
| 3.49M | $80.34M | 0.85% | Add | |
| 1.93M | $44.30M | 15.83% | Hold | |
| 1.90M | $43.62M | 24.66% | Hold | |
| 1.50M | $34.54M | 0.34% | Add | |
| 1.46M | $33.47M | 2.58% | Add | |
| 1.44M | $33.13M | 27.32% | Hold | |
| 1.46M | $32.11M | 0.00% | Add | |
| 1.28M | $29.45M | 55.80% | Hold | |
| 1.21M | $27.80M | 0.46% | Add | |
| 1.12M | $25.73M | 0.00% | Add | |
| 896.70K | $20.62M | 0.01% | New | |
| 879.73K | $20.22M | 0.03% | Reduce | |
| 847.39K | $19.48M | 0.12% | New | |
| 726.36K | $16.70M | 0.05% | New | |
| 678.59K | $15.60M | 2.19% | Add | |
| 673.57K | $15.49M | 0.00% | Add | |
| 625.50K | $14.38M | 0.93% | Add | |
| 589.00K | $13.54M | 11.22% | Hold | |
| 549.99K | $12.64M | 0.17% | Reduce | |
| 492.94K | $11.33M | 0.01% | Add | |
| 455.05K | $10.46M | 0.00% | New | |
| 448.35K | $10.31M | 0.22% | New | |
| 446.25K | $10.26M | 6.43% | Reduce | |
| 337.29K | $7.75M | 0.06% | New |
Q4 2025 — 25 funds
New Positions (Q2 2026)
- Vestal Point Capital, LP 1.00M sh · $13.29M
- Jupiter Topco LLC 896.70K sh · $11.92M
- Affinity Asset Advisors, LLC 500.10K sh · $6.65M
- GEODE CAPITAL MANAGEMENT, LLC 301.76K sh · $4.01M
- Balyasny Asset Management 170.00K sh · $2.26M
- ORBIMED ADVISORS LLC 161.00K sh · $2.14M
- Sixth Street Partners Management Company, L.P. 133.07K sh · $1.77M
- LMR Partners LLP 118.44K sh · $1.57M
- Longaeva Partners L.P. 116.61K sh · $1.55M
- Holocene Advisors, LP 111.13K sh · $1.48M
- Avidity Partners Management LP 75.00K sh · $996.75K
- Quadrature Capital Ltd 69.31K sh · $921.14K
Fully Exited (vs previous quarter)
- MPM BioImpact LLC sold 1.46M sh · $33.47M
- SymBiosis Capital Partners, LLC sold 1.28M sh · $29.45M
- Janus Henderson Group sold 896.70K sh · $20.62M
- Marshall Wace sold 879.73K sh · $20.22M
- Kynam Capital Management, LP sold 625.50K sh · $14.38M
- SECTORAL ASSET MANAGEMENT INC sold 589.00K sh · $13.54M
- PERCEPTIVE ADVISORS LLC sold 448.35K sh · $10.31M
- E Fund Management Co., Ltd. sold 243.70K sh · $5.60M
- Integral Health Asset Management, LLC sold 225.00K sh · $5.17M
- STEMPOINT CAPITAL LP sold 193.78K sh · $4.39M
- STATE STREET CORP sold 179.51K sh · $4.13M
- Monashee Investment Management LLC sold 179.34K sh · $4.12M
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 |
|---|---|---|---|---|
| EQT Fund Management S.a r.l. | 5.29M | 5.29M | 4.93M | 4.93M |
| Pivotal bioVenture Partners Investment Advisor LLC | 1.93M | 1.93M | 1.93M | 1.93M |
| Nan Fung Group Holdings Ltd | 1.44M | 1.44M | 1.44M | 1.44M |
| BlackRock Inc | 1.15M | 886.54K | 673.57K | 142.44K |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.00M | 881.89K | 455.05K | — |
| AMERICAN CENTURY COMPANIES INC | 762.34K | 755.02K | 492.94K | 417.45K |
| Qube Research & Technologies Ltd | 684.71K | 30.11K | — | 24.06K |
| SILVERARC CAPITAL MANAGEMENT, LLC | 594.03K | — | — | — |
| BARCLAYS PLC | 526.56K | 178.73K | 1.98K | — |
| Geode Capital Management | 467.27K | 301.76K | 248.61K | 109.78K |
| JANE STREET GROUP, LLC | 330.03K | 29.20K | — | — |
| STATE STREET CORP | 267.91K | — | 179.51K | 31.50K |
| BNP PARIBAS FINANCIAL MARKETS | 243.51K | 133.35K | 2.20K | — |
| Fidelity Management & Research (FMR) | 168.77K | 164 | 1.72K | — |
| Y-Intercept (Hong Kong) Ltd | 158.81K | 28.40K | — | — |
| Nuveen, LLC | 158.16K | 20.90K | 12.45K | — |
| VANGUARD FIDUCIARY TRUST CO | 152.82K | 88.20K | 72.58K | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 136.26K | 119.93K | 60.99K | — |
| HRT FINANCIAL LP | 127.31K | — | — | — |
| NEXTBio Capital Management LP | 119.06K | 119.06K | 184.06K | 228.29K |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold EVMN?
As of 2026-Q2, 111 institutional funds reported holding EVMN (EVOMMUNE INC) in SEC 13F filings, with a combined reported value of $466.41M.
How many shares of EVMN do institutions own?
13F filers reported 36.82M shares of EVMN, worth $466.41M in aggregate at the end of 2026-Q2.
Is institutional ownership of EVMN rising or falling?
Share counts moved +15.5% versus the prior quarter — accumulation.
Who are the top institutional holders of EVMN?
The largest 13F holders are RA CAPITAL MANAGEMENT, L.P., EQT Fund Management S.a r.l., MPM BioImpact LLC, SymBiosis Capital Partners, LLC, PRICE T ROWE ASSOCIATES INC /MD/; the top 25 are ranked at the top of this page.
Who are the major shareholders of EVOMMUNE INC?
The major shareholders of EVOMMUNE INC (EVMN) by reported 13F value are RA CAPITAL MANAGEMENT, L.P., EQT Fund Management S.a r.l., MPM BioImpact LLC, SymBiosis Capital Partners, LLC, PRICE T ROWE ASSOCIATES INC /MD/, among 151 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.